Pre_GI: SWBIT SVG BLASTP

Query: NC_020064:521500 Serratia marcescens FGI94, complete genome

Lineage: Serratia marcescens; Serratia; Enterobacteriaceae; Enterobacteriales; Proteobacteria; Bacteria

General Information: This organism was discovered in 1819 by Bizio who named the organism after the Italian physicist Serrati. It was considered a nonpathogenic organism until late in the 20th century, although pathogenicity was noted as early as 1913. Serratia marcescens is an opportunistic human pathogen that is increasingly associated with life-threatening hospital-acquired infections. It is an environmental organism that has a broad host range, and is capable of infecting vertebrates and invertebrates, as well as plants. In humans, Serratia marcescens can cause meningitis (inflammation of the membrane surrounding the brain and spinal cord), endocarditis (inflammation of heart muscle) and pyelonephritis (inflammation of the kidneys). Many strains are resistant to multiple antibiotics. Environmental isolates are noted by production of the red pigment prodigiosin.

- Sequence; - BLASTP hit: hover for score (Low score = Light, High score = Dark);
- hypothetical protein; - cds: hover for description

BLASTP Alignment.txt

Subject: NC_020410:3715210 Bacillus amyloliquefaciens subsp. plantarum UCMB5036 complete

Lineage: Bacillus amyloliquefaciens; Bacillus; Bacillaceae; Bacillales; Firmicutes; Bacteria

General Information: Bacillus amyloliquefaciens is a member of a group of free-living soil bacteria known to promote plant growth and suppress plant pathogens. Bacillus amyloliquefaciens is able to degrade myo-inositol hexakisphosphate (phytate), making phosphorus more available to plants. This organism also produces antifungal and antibacterial substances, such as bacillomycin D, surfactin, and bacillaene, which protect the plant from pathogenic organisms. In addition, proteases and amylases produced by Bacillus amyloliquefaciens are used in industrial applications.